Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two Medical Sciences Division scientists have been recognised in The Blavatnik Family Foundation and the New York Academy of Sciences Blavatnik Awards for Young Scientists, the largest unrestricted cash prizes available to scientists under the age of 42.

Eleanor Stride and Timothy Behrens

Professor Behrens and Professor Stride have been recognised in The Blavatnik Family Foundation and the New York Academy of Sciences Blavatnik Awards for Young Scientists, the largest unrestricted cash prizes available to scientists under the age of 42. 

Professor Timothy Behrens, from the Nuffield Department of Clinical Neuroscience (NDCN) at the University of Oxford receives a Laureateship worth £75,000 in the Life Sciences category. He has developed innovative models for mapping the brain's electrical signals that have significant implications for brain surgery, the treatment of mental disorders, and artificial intelligence.

Professor Eleanor Stride, from the Department of Engineering Science and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford, receives an award worth £23,000 as a Finalist. She is pioneering radical microbubble technology to develop more effective cancer treatments.

Read more about Timothy Behrens' research on the NDCN website

Read more about Eleanor Strides' research on the NDORMS website

Read the full story on University of Oxford website

Similar stories

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.